Key details
Sponsor
Hansoh BioMedical R&D Company
Enrollment target
~84 participants
Primary completion
June 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 45 Years
Last updated October 2024